Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Imago Biosciences Inc (IMGO)

Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,217,930
  • Shares Outstanding, K 33,822
  • Annual Sales, $ 0 K
  • Annual Income, $ -42,310 K
  • 60-Month Beta 2.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.04
Trade IMGO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.40
  • Most Recent Earnings $-0.50 on 11/09/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.54
  • Number of Estimates 5
  • High Estimate -0.52
  • Low Estimate -0.57
  • Prior Year -0.44
  • Growth Rate Est. (year over year) -22.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.74 +0.76%
on 12/15/22
36.09 -0.22%
on 12/21/22
+0.09 (+0.25%)
since 12/09/22
3-Month
14.36 +150.77%
on 11/08/22
36.09 -0.22%
on 12/21/22
+20.44 (+131.28%)
since 10/10/22
52-Week
11.56 +211.51%
on 06/16/22
36.09 -0.22%
on 12/21/22
+16.08 (+80.68%)
since 01/10/22

Most Recent Stories

More News
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common...

MRK : 109.77 (-0.37%)
IMGO : 36.01 (+0.03%)
ALERT: Contact The M&A Class Action Firm Regarding Its Investigation of the Merger -LBAI, IMRA, IMGO, RBA, BNFT

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

IMGO : 36.01 (+0.03%)
RBA : 81.21 (+1.40%)
BNFT : 10.50 (+0.10%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, ELVT, LBC, OYST

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMGO : 36.01 (+0.03%)
ELVT : 1.8700 (+0.54%)
LBC : 9.15 (+0.55%)
OYST : 11.17 (+0.18%)
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EQ : 0.8648 (+2.89%)
IMGO : 36.01 (+0.03%)
MTCR : 0.5814 (-1.29%)
OPNT : 20.65 (-0.58%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, USER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ELVT : 1.8700 (+0.54%)
IMGO : 36.01 (+0.03%)
GRAY : 5.50 (-10.80%)
USER : 7.50 (-0.13%)
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Imago BioSciences,...

MRK : 109.77 (-0.37%)
IMGO : 36.01 (+0.03%)
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EQ : 0.8648 (+2.89%)
IMGO : 36.01 (+0.03%)
MTCR : 0.5814 (-1.29%)
OPNT : 20.65 (-0.58%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SAL

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMGO : 36.01 (+0.03%)
GRAY : 5.50 (-10.80%)
APEN : 10.00 (+0.81%)
SAL : 27.88 (+1.57%)
SHAREHOLDER ALERT: Weiss Law Reminds EQ, IMGO, MTCR, and OPNT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

EQ : 0.8648 (+2.89%)
IMGO : 36.01 (+0.03%)
MTCR : 0.5814 (-1.29%)
OPNT : 20.65 (-0.58%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OYST, LBC, ELVT, IMGO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

OYST : 11.17 (+0.18%)
LBC : 9.15 (+0.55%)
ELVT : 1.8700 (+0.54%)
IMGO : 36.01 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Imago BioSciences Inc. is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 36.05
2nd Resistance Point 36.04
1st Resistance Point 36.02
Last Price 36.01
1st Support Level 35.99
2nd Support Level 35.98
3rd Support Level 35.96

See More

52-Week High 36.09
Last Price 36.01
Fibonacci 61.8% 26.72
Fibonacci 50% 23.83
Fibonacci 38.2% 20.93
52-Week Low 11.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar